$OFIX
Orthofix Medical Inc. Stock $ofix

$ofix Overview Financials Valuation SEC Filings Company Website

2012 Q2 Form 10-Q Financial Statement

#000110465912052296 Filed on July 30, 2012

Income Statement

Concept	2012 Q2	2011 Q2
Revenue	$113.4M	$116.7M
YoY Change	-2.78%	-18.3%
Cost Of Revenue	$27.55M	$23.19M
YoY Change	18.81%	-32.01%
Gross Profit	$85.88M	$93.48M
YoY Change	-8.14%	-14.08%
Gross Profit Margin	75.71%	80.13%
Selling, General & Admin	$61.37M	$67.30M
YoY Change	-8.82%	-13.27%
% of Gross Profit	71.46%	72.0%
Research & Development	$9.252M	$6.229M
YoY Change	48.53%	-25.85%
% of Gross Profit	10.77%	6.66%
Depreciation & Amortization	$5.400M	$6.000M
YoY Change	-10.0%	22.45%
% of Gross Profit	6.29%	6.42%
Operating Expenses	$71.58M	$74.09M
YoY Change	-3.39%	-15.13%
Operating Profit	$14.30M	$19.40M
YoY Change	-26.28%	-9.79%
Interest Expense	$1.265M	$2.198M
YoY Change	-42.45%	-148.84%
% of Operating Profit	8.85%	11.33%
Other Income/Expense, Net	-$605.0K	-$2.540M
YoY Change	-76.18%	-2640.0%
Pretax Income	$13.69M	$16.86M
YoY Change	-18.76%	0.33%
Income Tax	$3.823M	$6.337M
% Of Pretax Income	27.92%	37.59%
Net Earnings	$7.254M	$9.958M
YoY Change	-27.15%	-2.37%
Net Earnings / Revenue	6.4%	8.54%
Basic Earnings Per Share	$0.38	$0.55
Diluted Earnings Per Share	$0.37	$0.54
COMMON SHARES
Basic Shares Outstanding	18.83M shares	18.11M shares
Diluted Shares Outstanding	19.22M shares	18.54M shares

Balance Sheet

Concept	2012 Q2	2011 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$50.10M	$27.50M
YoY Change	82.18%	39.59%
Cash & Equivalents	$50.09M	$27.50M
Short-Term Investments
Other Short-Term Assets	$118.4M	$66.10M
YoY Change	79.12%	-11.28%
Inventory	$78.40M	$98.00M
Prepaid Expenses
Receivables	$149.5M	$139.2M
Other Receivables	$0.00	$15.30M
Total Short-Term Assets	$396.4M	$346.1M
YoY Change	14.53%	12.66%
LONG-TERM ASSETS
Property, Plant & Equipment	$45.30M	$49.20M
YoY Change	-7.93%	23.0%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$31.30M	$29.80M
YoY Change	5.03%	24.17%
Total Long-Term Assets	$134.0M	$300.9M
YoY Change	-55.47%	6.4%
TOTAL ASSETS
Total Short-Term Assets	$396.4M	$346.1M
Total Long-Term Assets	$134.0M	$300.9M
Total Assets	$530.4M	$647.0M
YoY Change	-18.02%	9.66%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$11.60M	$18.40M
YoY Change	-36.96%	-24.9%
Accrued Expenses	$83.90M	$46.00M
YoY Change	82.39%
Deferred Revenue
YoY Change
Short-Term Debt	$500.0K	$2.400M
YoY Change	-79.17%	-14.29%
Long-Term Debt Due	$0.00	$12.50M
YoY Change	-100.0%	278.79%
Total Short-Term Liabilities	$146.0M	$133.2M
YoY Change	9.61%	62.84%
LONG-TERM LIABILITIES
Long-Term Debt	$40.00M	$201.2M
YoY Change	-80.12%	-9.98%
Other Long-Term Liabilities	$3.300M	$7.200M
YoY Change	-54.17%	200.0%
Total Long-Term Liabilities	$43.30M	$208.4M
YoY Change	-79.22%	-7.75%
TOTAL LIABILITIES
Total Short-Term Liabilities	$146.0M	$133.2M
Total Long-Term Liabilities	$43.30M	$208.4M
Total Liabilities	$205.2M	$349.1M
YoY Change	-41.22%	11.11%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$325.2M	$297.9M
YoY Change
Total Liabilities & Shareholders Equity	$530.4M	$647.0M
YoY Change	-18.02%	9.66%

Cashflow Statement

Concept	2012 Q2	2011 Q2
OPERATING ACTIVITIES
Net Income	$7.254M	$9.958M
YoY Change	-27.15%	-2.37%
Depreciation, Depletion And Amortization	$5.400M	$6.000M
YoY Change	-10.0%	22.45%
Cash From Operating Activities	$8.700M	$4.600M
YoY Change	89.13%	-70.51%
INVESTING ACTIVITIES
Capital Expenditures	-$6.500M	-$5.600M
YoY Change	16.07%	-25.33%
Acquisitions
YoY Change
Other Investing Activities	$153.1M	$0.00
YoY Change
Cash From Investing Activities	$146.6M	-$5.600M
YoY Change	-2717.86%	-25.33%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-151.8M	4.900M
YoY Change	-3197.96%	-174.24%
NET CHANGE
Cash From Operating Activities	8.700M	4.600M
Cash From Investing Activities	146.6M	-5.600M
Cash From Financing Activities	-151.8M	4.900M
Net Change In Cash	3.500M	3.900M
YoY Change	-10.26%	160.0%
FREE CASH FLOW
Cash From Operating Activities	$8.700M	$4.600M
Capital Expenditures	-$6.500M	-$5.600M
Free Cash Flow	$15.20M	$10.20M
YoY Change	49.02%	-55.84%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-1.45
	ofix	Number Of Reporting Segments NumberOfReportingSegments	2	segment
	us-gaap	Comparability Of Prior Year Financial Data ComparabilityOfPriorYearFinancialData	<table style="font-size:10pt; font-family:'Times New Roman',times,serif;"> <tr> <td> <p style="MARGIN: 0in 0in 0pt 41.05pt; TEXT-INDENT: -0.25in"><b><font style="FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" size="2">(b)</font></b><b><font style="FONT-WEIGHT: bold; FONT-SIZE: 3pt" size="1">          </font></b><b><font style="FONT-WEIGHT: bold; FONT-SIZE: 10pt" size="2">Reclassifications</font></b></p> <p style="MARGIN: 0in 0in 0pt 41.05pt; TEXT-INDENT: -0.25in"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" size="2"> </font></p> <p style="MARGIN: 0in 0in 0pt; TEXT-INDENT: 0.5in"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" size="2">The Company has reclassified certain line items to conform to the current year presentation. The reclassifications have no effect on previously reported net earnings or shareholders’ equity.</font></p></td></tr></table>
	us-gaap	Use Of Estimates UseOfEstimates	<table style="font-size:10pt; font-family:'Times New Roman',times,serif;"> <tr> <td> <p style="MARGIN: 0in 0in 0pt 41.05pt; TEXT-INDENT: -0.25in"><b><font style="FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" size="2">(c)</font></b><b><font style="FONT-WEIGHT: bold; FONT-SIZE: 3pt" size="1">          </font></b><b><font style="FONT-WEIGHT: bold; FONT-SIZE: 10pt" size="2">Use of estimates</font></b></p> <p style="MARGIN: 0in 0in 0pt 41.05pt; TEXT-INDENT: -0.25in"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" size="2"> </font></p> <p style="MARGIN: 0in 0in 0pt; TEXT-INDENT: 23pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" size="2">The preparation of financial statements in conformity with accounting principles generally accepted in the U.S. requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. On an ongoing basis, the Company evaluates its estimates including those related to the resolution of U.S. government matters, contractual allowances, doubtful accounts, inventories, taxes, shared-based compensation, and potential goodwill and intangible asset impairment. Actual results could differ from these estimates.</font></p></td></tr></table>
CY2011Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	10115000	USD
CY2011Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	5606000	USD
CY2011Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	49141000	USD
CY2011Q4	ofix	Inventory Field InventoryField	39400000	USD
CY2011Q4	us-gaap	Other Inventory Materials Supplies And Merchandise Under Consignment OtherInventoryMaterialsSuppliesAndMerchandiseUnderConsignment	7551000	USD
CY2011Q4	us-gaap	Inventory Gross InventoryGross	111813000	USD
CY2011Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	28844000	USD
CY2012Q2	us-gaap	Inventory Raw Materials InventoryRawMaterials	8017000	USD
CY2012Q2	us-gaap	Inventory Work In Process InventoryWorkInProcess	5874000	USD
CY2012Q2	us-gaap	Inventory Finished Goods InventoryFinishedGoods	44244000	USD
CY2012Q2	ofix	Inventory Field InventoryField	38954000	USD
CY2012Q2	us-gaap	Other Inventory Materials Supplies And Merchandise Under Consignment OtherInventoryMaterialsSuppliesAndMerchandiseUnderConsignment	7317000	USD
CY2012Q2	us-gaap	Inventory Gross InventoryGross	104406000	USD
CY2012Q2	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	25983000	USD
CY2011Q4	ofix	Intangible Assets Gross IntangibleAssetsGross	38228000	USD
CY2012Q2	ofix	Intangible Assets Gross IntangibleAssetsGross	33028000	USD
	us-gaap	Future Amortization Expense Remainder Of Fiscal Year FutureAmortizationExpenseRemainderOfFiscalYear	1000000	USD
	us-gaap	Future Amortization Expense Year One FutureAmortizationExpenseYearOne	2000000	USD
	us-gaap	Future Amortization Expense Year Two FutureAmortizationExpenseYearTwo	1300000	USD
	us-gaap	Future Amortization Expense Year Three FutureAmortizationExpenseYearThree	1300000	USD
	us-gaap	Future Amortization Expense Year Four FutureAmortizationExpenseYearFour	900000	USD
	ofix	Future Amortization Expense After Fourth Full Fiscal Year FutureAmortizationExpenseAfterFourthFullFiscalYear	800000	USD
	us-gaap	Goodwill Translation Adjustments GoodwillTranslationAdjustments	17000	USD
CY2011Q4	us-gaap	Line Of Credit Facility Amount Outstanding LineOfCreditFacilityAmountOutstanding	1300000	USD
CY2012Q2	us-gaap	Line Of Credit Facility Amount Outstanding LineOfCreditFacilityAmountOutstanding	500000	USD
CY2011Q4	us-gaap	Line Of Credit Facility Interest Rate At Period End LineOfCreditFacilityInterestRateAtPeriodEnd	0.0402	pure
CY2012Q2	us-gaap	Line Of Credit Facility Interest Rate At Period End LineOfCreditFacilityInterestRateAtPeriodEnd	0.0341	pure
CY2012Q2	us-gaap	Amount Of Restricted Net Assets For Consolidated And Unconsolidated Subsidiaries AmountOfRestrictedNetAssetsForConsolidatedAndUnconsolidatedSubsidiaries	200000000	USD
CY2011Q4	us-gaap	Amount Of Restricted Net Assets For Consolidated And Unconsolidated Subsidiaries AmountOfRestrictedNetAssetsForConsolidatedAndUnconsolidatedSubsidiaries	186000000	USD
	us-gaap	Other Comprehensive Income Derivatives Qualifying As Hedges Tax Portion Attributable To Parent OtherComprehensiveIncomeDerivativesQualifyingAsHedgesTaxPortionAttributableToParent	-44000	USD
CY2012Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	11205000	USD
CY2011Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	9958000	USD
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	23221000	USD
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-25843000	USD
CY2012Q2	us-gaap	Other Comprehensive Income Derivatives Qualifying As Hedges Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToParent	-585000	USD
CY2011Q2	us-gaap	Other Comprehensive Income Derivatives Qualifying As Hedges Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToParent	199000	USD
	us-gaap	Other Comprehensive Income Derivatives Qualifying As Hedges Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToParent	-76000	USD
	us-gaap	Other Comprehensive Income Derivatives Qualifying As Hedges Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToParent	1301000	USD
CY2012Q2	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-3798000	USD
CY2011Q2	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	1636000	USD
	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-1597000	USD
	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	3624000	USD
CY2012Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	6822000	USD
CY2011Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	11793000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	21548000	USD
CY2011Q2	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	0.58
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-20918000	USD
CY2011Q2	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	430613	shares
	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	417367	shares
CY2012Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	18827452	shares
CY2011Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	18110607	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	18751573	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	18024913	shares
CY2012Q2	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	388532	shares
CY2012Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	19215984	shares
CY2011Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	18541220	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	19168940	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	18024913	shares
CY2012Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1305000	USD
CY2011Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	2372000	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	2378000	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	3768000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	13356000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	12056000	USD
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.338	pure
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.851	pure
	ofix	Effective Income Tax Rate Continuing Operations Excluding Impact Of Tax Settlement EffectiveIncomeTaxRateContinuingOperationsExcludingImpactOfTaxSettlement	0.370	pure
CY2012Q2	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	600000	USD
CY2011Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	700000	USD
CY2012Q2	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	500000	USD
CY2011Q4	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	500000	USD
	ofix	Number Of Global Business Units NumberOfGlobalBusinessUnits	2	unit
CY2011Q2	us-gaap	Sales Revenue Net SalesRevenueNet	116670000	USD
CY2012Q2	us-gaap	Sales Revenue Net SalesRevenueNet	119492000	USD
	us-gaap	Sales Revenue Net SalesRevenueNet	229731000	USD
	us-gaap	Sales Revenue Net SalesRevenueNet	235534000	USD
CY2011Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	97254000	USD
CY2011Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	1761000	USD
CY2011Q4	us-gaap	Stockholders Equity StockholdersEquity	315171000	USD
CY2011Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	19396000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-8101000	USD
CY2011Q2	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	23186000	USD
CY2012Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	20565000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	42996000	USD
	dei	Entity Registrant Name EntityRegistrantName	ORTHOFIX INTERNATIONAL N V
	dei	Entity Central Index Key EntityCentralIndexKey	0000884624
	dei	Document Type DocumentType	10-Q
	dei	Document Period End Date DocumentPeriodEndDate	2012-06-30
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2012
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
CY2012Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2011Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2011Q4	us-gaap	Common Stock Value CommonStockValue	1846000	USD
CY2011Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	214310000	USD
CY2011Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	704472000	USD
CY2012Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	553320000	USD
CY2012Q2	us-gaap	Stockholders Equity StockholdersEquity	354216000	USD
CY2012Q2	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	11072000	USD
CY2011Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	9376000	USD
CY2012Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.10
CY2011Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.10
CY2012Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000	shares
CY2012Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	18968031	shares
CY2011Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000	shares
CY2012Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	18946481	shares
CY2011Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	18465444	shares
CY2012Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	18946481	shares
CY2011Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	18465444	shares
CY2011Q2	us-gaap	Gross Profit GrossProfit	93484000	USD
CY2011Q2	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	49960000	USD
CY2011Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	17344000	USD
CY2011Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	6229000	USD
CY2011Q2	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	555000	USD
CY2011Q2	us-gaap	Operating Expenses OperatingExpenses	74088000	USD
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	45527000	USD
	us-gaap	Gross Profit GrossProfit	184204000	USD
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	97399000	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	36130000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	11673000	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1103000	USD
	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	-46000000	USD
	us-gaap	Operating Expenses OperatingExpenses	192305000	USD
CY2011Q2	us-gaap	Interest Expense InterestExpense	2198000	USD
CY2011Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-342000	USD
CY2011Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-2540000	USD
	us-gaap	Interest Expense InterestExpense	4613000	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-1451000	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-6064000	USD
CY2011Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	16856000	USD
CY2011Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	6337000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-14165000	USD
CY2012Q2	us-gaap	Discontinued Operation Gain Loss On Disposal Of Discontinued Operation Net Of Tax DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax	1040000	USD
	us-gaap	Discontinued Operation Gain Loss On Disposal Of Discontinued Operation Net Of Tax DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax	1040000	USD
CY2011Q2	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	-0.03
CY2011Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.55
	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-1.45
	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	0.02
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.43
CY2011Q2	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	0.57
CY2011Q2	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	-0.03
CY2011Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.54
	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	0.02
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.43
CY2012Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	19960000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	39539000	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-3457000	USD
CY2012Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-605000	USD
CY2012Q2	us-gaap	Operating Expenses OperatingExpenses	75251000	USD
	us-gaap	Operating Expenses OperatingExpenses	146922000	USD
CY2012Q2	us-gaap	Gross Profit GrossProfit	95816000	USD
	us-gaap	Gross Profit GrossProfit	189918000	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	11324000	USD
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	643000	USD
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	4545000	USD
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-2680000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	3997000	USD
	us-gaap	Inventory Write Down InventoryWriteDown	2116000	USD
	us-gaap	Excess Tax Benefit From Share Based Compensation Operating Activities ExcessTaxBenefitFromShareBasedCompensationOperatingActivities	1004000	USD
	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-335000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	5353000	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	12423000	USD
	us-gaap	Increase Decrease In Security Deposits IncreaseDecreaseInSecurityDeposits	-326000	USD
	ofix	Increase Decrease In Prepaid Expense And Other Current Assets IncreaseDecreaseInPrepaidExpenseAndOtherCurrentAssets	-3704000	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-2312000	USD
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	46000000	USD
	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	680000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	23403000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	10963000	USD
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	335000	USD
	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	5250000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-16548000	USD
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	13453000	USD
	us-gaap	Repayments Of Secured Debt RepaymentsOfSecuredDebt	2500000	USD
	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	758000	USD
	us-gaap	Proceeds From Repayments Of Short Term Debt ProceedsFromRepaymentsOfShortTermDebt	-1653000	USD
	us-gaap	Proceeds From Repayments Of Restricted Cash Financing Activities ProceedsFromRepaymentsOfRestrictedCashFinancingActivities	-2285000	USD
	us-gaap	Payments To Acquire Additional Interest In Subsidiaries PaymentsToAcquireAdditionalInterestInSubsidiaries	517000	USD
	us-gaap	Excess Tax Benefit From Share Based Compensation Financing Activities ExcessTaxBenefitFromShareBasedCompensationFinancingActivities	1004000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	6744000	USD
	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents Continuing Operations EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations	325000	USD
	us-gaap	Net Cash Provided By Used In Continuing Operations NetCashProvidedByUsedInContinuingOperations	13924000	USD
	us-gaap	Net Cash Provided By Used In Continuing Operations NetCashProvidedByUsedInContinuingOperations	16882000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	-180860000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	57756000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	140084000	USD
	us-gaap	Nature Of Operations NatureOfOperations	<table style="font-size:10pt; font-family:'Times New Roman',times,serif;"> <tr> <td> <p style="MARGIN: 0in 0in 0pt"> </p> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" size="2"> </font></p> <p style="MARGIN: 0in 0in 0pt 23.05pt; TEXT-INDENT: -23.05pt"><b><font style="FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" size="2">1.</font></b><b><font style="FONT-WEIGHT: bold; FONT-SIZE: 3pt" size="1">                     </font></b><b><font style="FONT-WEIGHT: bold; FONT-SIZE: 10pt" size="2">Description of business</font></b></p> <p style="MARGIN: 0in 0in 0pt 0.25in; TEXT-INDENT: -0.25in"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" size="2"> </font></p> <p style="MARGIN: 0in 0in 0pt; TEXT-INDENT: 0.25in"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" size="2">Orthofix International N.V. (the “Company”) is a diversified, global medical device company focused on developing and delivering innovative repair and regenerative technologies to the spine and orthopedic markets. The Company is comprised of two reportable segments: Spine and Orthopedics that are supported by Corporate activities.</font></p> <p style="MARGIN: 0in 0in 0pt; TEXT-INDENT: 0.25in"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" size="2"> </font></p> <p style="MARGIN: 0in 0in 0pt; TEXT-INDENT: 23.05pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" size="2">On May 24, 2012 (the “Closing Date” of the Transaction), Orthofix Holdings Inc. (“Orthofix Holdings”) completed the sale of all of the outstanding shares of Breg, Inc (“Breg”) for $157.5 million in cash. Beginning June 30, 2012, the former sports medicine business is presented as discontinued operations for all periods.  As a result of the sale of Breg, the Company completed its exit from the Sports Medicine global business unit (“GBU”), of which Breg was a significant component. The operations and cash flows of the former Sports Medicine GBU have been eliminated from the ongoing operations, and there is no significant continuing involvement in the sold business. See Note 15 for detailed information on the discontinued operations.</font></p></td></tr></table>

Files In Submission

Name	View Source	Status
0001104659-12-052296-index-headers.html	Edgar Link	pending
0001104659-12-052296-index.html	Edgar Link	pending
0001104659-12-052296.txt	Edgar Link	pending
0001104659-12-052296-xbrl.zip	Edgar Link	pending
a12-13748_110q.htm	Edgar Link	pending
a12-13748_1ex10d11.htm	Edgar Link	pending
a12-13748_1ex10d23.htm	Edgar Link	pending
a12-13748_1ex10d7.htm	Edgar Link	pending
a12-13748_1ex31d1.htm	Edgar Link	pending
a12-13748_1ex31d2.htm	Edgar Link	pending
a12-13748_1ex32d1.htm	Edgar Link	pending
a12-13748_1ex32d2.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xls	Edgar Link	pending
ofix-20120630.xml	Edgar Link	completed
ofix-20120630.xsd	Edgar Link	pending
ofix-20120630_cal.xml	Edgar Link	unprocessable
ofix-20120630_def.xml	Edgar Link	unprocessable
ofix-20120630_lab.xml	Edgar Link	unprocessable
ofix-20120630_pre.xml	Edgar Link	unprocessable
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$OFIX
Orthofix Medical Inc. Stock $ofix

2012 Q2 Form 10-Q Financial Statement

#000110465912052296 Filed on July 30, 2012

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$OFIX Orthofix Medical Inc. Stock $ofix

2012 Q2 Form 10-Q Financial Statement

#000110465912052296 Filed on July 30, 2012

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$OFIX
Orthofix Medical Inc. Stock $ofix